These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Triple therapy with low-dose cyclosporine, azathioprine, and steroids: long-term results of a randomized study in cadaver donor renal transplantation. Fries D; Hiesse C; Santelli G; Gardin JP; Cantarovich M; Lantz O; Charpentier B; Paillard M; Benoit G Transplant Proc; 1988 Jun; 20(3 Suppl 3):130-5. PubMed ID: 3291226 [No Abstract] [Full Text] [Related]
25. Combination therapy of cyclosporine and azathioprine in living-related kidney transplant recipients compared with patients converted totally from cyclosporine to azathioprine. Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Nakai I Transplant Proc; 1988 Jun; 20(3 Suppl 3):143-6. PubMed ID: 3291229 [No Abstract] [Full Text] [Related]
26. Long-term results of controlled cyclosporine conversion at 3 months after renal transplantation. Kootte AM; van Dorp WT; van Bockel JH; van Es LA; Paul LC Transplant Proc; 1989 Feb; 21(1 Pt 2):1585-6. PubMed ID: 2652515 [No Abstract] [Full Text] [Related]
27. Conversion from cyclosporine to azathioprine after renal transplantation: long-term effects on renal function, rejection, and allograft survival. Maddux MS; Veremis SA; Bauma WD; Pollak R; Mozes MF Transplant Proc; 1988 Jun; 20(3 Suppl 3):152-4. PubMed ID: 3291231 [No Abstract] [Full Text] [Related]
28. Randomized prospective trial of elective cyclosporine withdrawal from triple therapy at 6 months after cadaveric renal transplantation. Hiesse C; Neyrat N; Deglise-Favre A; Lantz O; Bensadoun H; Benoit G; Charpentier B; Fries D Transplant Proc; 1991 Feb; 23(1 Pt 2):987-9. PubMed ID: 1989354 [No Abstract] [Full Text] [Related]
29. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality. Light JA; Aquino A; Ali A; Rodriguez R; Ali S Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897 [No Abstract] [Full Text] [Related]
30. Cyclosporin A (CsA) and azathioprine (Aza) overlap in renal allografts with impaired renal function. Castelao AM; Griñó JM; Sabaté I; Gilvernet S; Andres E; Sabater R; Alsina J Transplant Proc; 1989 Feb; 21(1 Pt 2):1540-1. PubMed ID: 2652497 [No Abstract] [Full Text] [Related]
31. A retrospective analysis of long-term renal allograft function associated with cyclosporine-prednisone immunosuppressive therapy. Lewis RM; Janney RP; Van Buren CT; Kerman RH; Herson J; Kerr NA; Golden DA; Kahan BD Transplant Proc; 1988 Jun; 20(3 Suppl 3):534-9. PubMed ID: 3291291 [No Abstract] [Full Text] [Related]
32. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants. Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888 [No Abstract] [Full Text] [Related]
33. Conversion of long-term renal allograft recipients from prednisolone/azathioprine to cyclosporine monotherapy. Birkeland SA; Foged N; Kold AA; Svendsen V; Rohr N; Elbirk A Transplant Proc; 1988 Jun; 20(3 Suppl 3):171-5. PubMed ID: 3291237 [No Abstract] [Full Text] [Related]
34. Cyclosporine treatment with conversion after three months is a safe treatment protocol in renal allograft recipients. Hoitsma AJ; Tiggeler RG; Wetzels JF; Berden JH; Koene RA Transplant Proc; 1988 Jun; 20(3 Suppl 3):161-3. PubMed ID: 3291234 [No Abstract] [Full Text] [Related]
35. Consequences of conversion from cyclosporine to conventional therapy in renal transplantation. Abbud-Filho M; Barberato JB; Ramalho HJ; Saldanha LB; Casassanta DM; Denadai ER; Zerati S; Bezas AG Transplant Proc; 1989 Feb; 21(1 Pt 2):1638-40. PubMed ID: 2652535 [No Abstract] [Full Text] [Related]